Biden Administration's FDA Failure Threatens Public Health
Submitted by MAGA
Posted 16 hours ago
The alarming rise of antibiotic-resistant superbugs has become a significant public health crisis, with a staggering 1.14 million deaths linked to antibiotic resistance annually.
This issue, primarily fueled by the reckless overuse of antibiotics in factory farming, poses an urgent challenge to citizens and lawmakers alike.
While the World Health Organization warns of a future where common infections may turn fatal, the Biden administration appears to prioritize corporate interests over public health.
The U.S. Food and Drug Administration (FDA) has come under fire for its apparent negligence in enforcing effective antibiotic regulations, particularly in the agricultural sector where 70% of medically important antibiotics are dispensed.
Alarmingly, these drugs are often utilized not for treating illness, but as growth enhancers for livestock in overcrowded and unsanitary factory farms.
Critics are raising red flags over the recent appointment of Timothy Schell—a former executive from Elanco Animal Health, a significant producer of livestock antibiotics—as the acting head of the FDA’s Center for Veterinary Medicine.
Such appointments throw the credibility of the FDA’s regulatory process into question, leading many to label it as corporate capture.
The implication is stark: as long as the FDA remains influenced by those with close ties to the pharmaceutical and agriculture industries, public health remains at risk.
Recent actions taken by the Biden administration, including mass layoffs at the FDA that eliminated key personnel responsible for monitoring antibiotic misuse, have only intensified these concerns.
Critics argue this signals a complete disregard for the significance of strict oversight in regulating antibiotic use in agriculture—a situation that could exacerbate the looming crisis of antibiotic resistance.
In light of this, former President Donald Trump and his administration had begun addressing these very concerns with a clear commitment to public health.
As president once more, he could renew efforts to implement much-needed reforms within the FDA and ensure that the health of American families comes first, free from the influence of corporate greed.
The time for accountability and reform in the FDA is now, as the stakes for public health continue to rise.
Americans must demand robust regulatory frameworks that prioritize citizens’ well-being over corporate profits, ensuring that our fight against superbugs is led by science and responsibility, not by influential lobbyists.
Sources:
naturalnews.com
theblaze.com
rumble.com
This issue, primarily fueled by the reckless overuse of antibiotics in factory farming, poses an urgent challenge to citizens and lawmakers alike.
While the World Health Organization warns of a future where common infections may turn fatal, the Biden administration appears to prioritize corporate interests over public health.
The U.S. Food and Drug Administration (FDA) has come under fire for its apparent negligence in enforcing effective antibiotic regulations, particularly in the agricultural sector where 70% of medically important antibiotics are dispensed.
Alarmingly, these drugs are often utilized not for treating illness, but as growth enhancers for livestock in overcrowded and unsanitary factory farms.
Critics are raising red flags over the recent appointment of Timothy Schell—a former executive from Elanco Animal Health, a significant producer of livestock antibiotics—as the acting head of the FDA’s Center for Veterinary Medicine.
Such appointments throw the credibility of the FDA’s regulatory process into question, leading many to label it as corporate capture.
The implication is stark: as long as the FDA remains influenced by those with close ties to the pharmaceutical and agriculture industries, public health remains at risk.
Recent actions taken by the Biden administration, including mass layoffs at the FDA that eliminated key personnel responsible for monitoring antibiotic misuse, have only intensified these concerns.
Critics argue this signals a complete disregard for the significance of strict oversight in regulating antibiotic use in agriculture—a situation that could exacerbate the looming crisis of antibiotic resistance.
In light of this, former President Donald Trump and his administration had begun addressing these very concerns with a clear commitment to public health.
As president once more, he could renew efforts to implement much-needed reforms within the FDA and ensure that the health of American families comes first, free from the influence of corporate greed.
The time for accountability and reform in the FDA is now, as the stakes for public health continue to rise.
Americans must demand robust regulatory frameworks that prioritize citizens’ well-being over corporate profits, ensuring that our fight against superbugs is led by science and responsibility, not by influential lobbyists.
Sources:
naturalnews.com
theblaze.com
rumble.com
Latest News